An update on respiratory syncytial virus epidemiology: a developed country perspective

被引:108
作者
Law, BJ
Carbonell-Estrany, X
Simoes, EAF
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada
[2] Inst Clin Ginecol, Hosp Clin, Barcelona, Spain
[3] Univ Colorado, Sch Med, Dept Pediat, Infect Dis Sect, Denver, CO USA
[4] Childrens Hosp, Denver, CO 80218 USA
关键词
lower respiratory tract infection; prematurity; palivizumab; prophylaxis; respiratory syncytial virus; epidemiology;
D O I
10.1053/rmed.2002.1294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children worldwide, and an important cause of morbidity, hospitalization, and mortality. The infections caused by RSV are seasonal, peaking predictably in the winter months in temperate climates, and in the hottest months and the rainy season in tropical climates. The involvement of the lower respiratory tract, manifest clinically as bronchiolitis or pneumonia, is the hallmark of severe RSV disease, Other indicators of severe disease include requirement for, and duration of, hospitalization, supplemental oxygen, management in an intensive care setting, and mechanical ventilation, Host-related risk factors for severe RSV disease include preterm birth, infection before 6 months of age, chronic lung disease, and congenital heart disease, Environmental risk factors for severe RSV infection include poverty, crowding, exposure to tobacco smoke, and malnutrition, Factors that increase frequency of the infection include young age, multiple gestation, family history of atopy, lack of parental education, household crowding, older school-age siblings, lack of breast feeding, day-care attendance, passive smoke exposure, and discharge from a neonatal intensive care unit between September and December, Recent studies in Europe, North America and Japan have evaluated the number of children affected as well as the medical resources necessary to care for these children. Continuing surveillance is the key to tracking the seasonality, risk factors, morbidity and mortality associated with RSV infection. Epidemiological studies are also the basis for development of appropriate local prevention strategies. (C) 2002 Elsevier Science Ltd.
引用
收藏
页码:S1 / S7
页数:7
相关论文
共 29 条
  • [11] RISK OF PRIMARY INFECTION AND REINFECTION WITH RESPIRATORY SYNCYTIAL VIRUS
    GLEZEN, WP
    TABER, LH
    FRANK, AL
    KASEL, JA
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (06): : 543 - 546
  • [12] Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection
    Greenough, A
    Cox, S
    Alexander, J
    Lenney, W
    Turnbull, F
    Burgess, S
    Chetcuti, PAJ
    Shaw, NJ
    Woods, A
    Boorman, J
    Coles, S
    Turner, J
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 85 (06) : 463 - 468
  • [13] PROPHYLACTIC ADMINISTRATION OF RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN TO HIGH-RISK INFANTS AND YOUNG-CHILDREN
    GROOTHUIS, JR
    SIMOES, EAF
    LEVIN, MJ
    HALL, CB
    LONG, CE
    RODRIGUEZ, WJ
    ARROBIO, J
    MEISSNER, HC
    FULTON, DR
    WELLIVER, RC
    TRISTRAM, DA
    SIBER, GR
    PRINCE, GA
    VANRADEN, M
    HEMMING, VG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) : 1524 - 1530
  • [14] Respiratory syncyial virus pneumonia in the hospital setting: Length of stay, charges, and mortality
    Howard, TS
    Hoffman, LH
    Stang, PE
    Simoes, EAF
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (02) : 227 - 232
  • [15] KANEKO M, 2001, 5 WORLD C PER MED 23
  • [16] LANARI M, 2001, 5 WORLD C PER MED 23
  • [17] DOES PREMATURITY ALTER THE COURSE OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION
    MEERT, K
    HEIDEMANN, S
    ABELLA, B
    SARNAIK, A
    [J]. CRITICAL CARE MEDICINE, 1990, 18 (12) : 1357 - 1359
  • [18] IMPROVED OUTCOME OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN A HIGH-RISK HOSPITALIZED POPULATION OF CANADIAN CHILDREN
    NAVAS, L
    WANG, E
    DECARVALHO, V
    ROBINSON, J
    [J]. JOURNAL OF PEDIATRICS, 1992, 121 (03) : 348 - 354
  • [19] Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531
  • [20] RIETVELD E, 2001, EUR SOC PAED INF DIS